Skip to main content

Featured

AIR MILES Is Gone. Here's What Actually Earns You Travel Now

  If you've been holding onto a Air Miles card waiting to redeem for a flight, the program you signed up for doesn't exist anymore — and the cards that replaced it aren't the best game in town. If you searched "best AIR MILES credit card" and landed here, there's something you need to know first: there is no such thing anymore. AIR MILES, the loyalty program that's been part of Canadian wallets since 1992, officially became BMO Blue Rewards on June 2, 2026. BMO had already stopped issuing new AIR MILES cards back in January, and every collector's Miles converted automatically into Blue Points at a rate of roughly 1 Air Mile to 15.79 Blue Points — no action needed, no lost value. That's good news if you're a longtime collector sitting on a pile of Miles. It's less good news if you were hoping to earn free flights that way going forward, because Blue Rewards was built to compete with PC Optimum and Scene+ — grocery, gas, and everyday spendi...

article

Pharmacare in Canada: A Dream or a Reality?

 


The fate of Canada's pharmacare plan is uncertain as the federal government faces challenges in implementing a universal drug coverage program, even if a bill to create one passes in Parliament. Bill C-213, the Canada Pharmacare Act, aims to establish a national framework for pharmacare that would ensure all Canadians have access to prescription drugs based on their medical needs, not their ability to pay. 

However, the bill does not specify how the program would be funded, administered or negotiated with the provinces and territories, leaving many questions unanswered about the feasibility and cost-effectiveness of pharmacare. Some experts and stakeholders have expressed doubts about whether Ottawa has the political will, the constitutional authority and the fiscal capacity to deliver on its promise of pharmacare, especially in the wake of the COVID-19 pandemic that has strained the health care system and the public purse.

Comments